Adicet Bio, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
9.36M
on 2026-06-30, from 5.14M on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-16 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
$100.0M
Jefferies, agreement of 2025-03-18. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-05 is not read yet.
Cash
1.6 quarters
$33.1M on 2026-06-30 ÷ $21.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-10-07 | Registered direct offering incl. 10.00M pre-funded | 80,001,000 | $1.00 | $80.0M | 424B5 ↗ |
Also on file: a 1-for-16 reverse split, 2025-12-26 8-K ↗